Target intelligence / Profile preview

Alginate (Pseudomonas aeruginosa)

Molecular classification: Exopolysaccharide, Polysaccharide

Overview

Alginate is an exopolysaccharide produced by Pseudomonas aeruginosa, particularly in chronic infections like those found in cystic fibrosis (CF). It plays a central role in biofilm formation, bacterial protection, and persistence within host tissues, leading to increased antibiotic resistance and immune evasion.

Mechanism of action

Alginate is not directly targeted by drugs; however, its presence reduces the efficacy of antibiotics like tobramycin.

Biological functions

Biofilm formationBacterial protectionImmune evasionAdhesion

Disease associations

Cystic FibrosisChronic infectionInfection

Safety considerations

Increased antibiotic resistancePersistent infectionBiofilm-related complications

Interacting drugs

Tobramycin

Biomarkers

Mucoid phenotype of Pseudomonas aeruginosa

Beyond the preview

Go deeper on Alginate (Pseudomonas aeruginosa).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alginate (Pseudomonas aeruginosa).

Explore the full profile